Clinical manifestations of pyoderma gangrenosum associated with inflammatory bowel disease

Israel Medical Association Journal

Volumn 6, Issue 2, 2004, Pages 88-90

  Menachem, Yoram ^a   Gotsman, Israel ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Immunomodulatory drugs; Inflammatory bowel disease; Pyoderma gantenosum

Indexed keywords

AZATHIOPRINE; BACITRACIN; CYCLOSPORIN; DAPSONE; IMMUNOMODULATING AGENT; IMMUNOSUPPRESSIVE AGENT; MESALAZINE; METHOTREXATE; SALAZOSULFAPYRIDINE; STEROID; TOPICAL AGENT;

ADJUVANT THERAPY; ADULT; AGED; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; CLINICAL FEATURE; COLON RESECTION; COMORBIDITY; CONTROLLED STUDY; CORRELATION FUNCTION; CROHN DISEASE; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG MEGADOSE; DRUG RESPONSE; ENTERITIS; ERYTHEMA NODOSUM; FEMALE; HOSPITALIZATION; HUMAN; INCIDENCE; MALE; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDY; SACROILIITIS; SEX RATIO; SKIN BIOPSY; SKIN DEFECT; SKIN GRAFT; TOPICAL TREATMENT; ULCERATIVE COLITIS; UNIVERSITY HOSPITAL;

ADULT; AGED; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; FEMALE; HUMANS; MALE; PYODERMA GANGRENOSUM; RETROSPECTIVE STUDIES;

EID: 1142267379     PISSN: 15651088     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Veloso FT, Carvalho J, Magro F. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. J Clin Gastroenterol 1996;23:29-34.
2. Apgar JT. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: A selective review. Semin Dermatol 1991;10:138-47.
3. Greenstein AJ, Janowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: A study of 700 patients. Medicine (Baltimore) 1976;55:401-12.
4. Schorr-Lesnick B, Brandt LJ. Selected rheumatologic and dermatologic manifestations of inflammatory bowel disease. Am J Gastroenterol 1988;83:216-23.
5. Levine JB, Lukawski-Trubish D. Extrainstestinal considerations in inflammatory bowel disease. Gastroenterol Clin North Am 1995;24:633-46.
6. Schoetz Jr. D.J, Coller JA, Veidenheimer MC. Pyoderma gangrenosum and Crohn's disease. Eight cases and a review of the literature. Dis Colon Rectum 1983;26:155-8.
7. Levitt MD, Ritchie JK, Lennard-Jones JE, Phillips RK. Pyoderma gangrenosum in inflammatory bowel disease. Br J Surg 1991;78:676-8.
8. Brunsting LA, Goeckerman WH, O'Leary PA. Pyoderma (ecthyma) gangrenosum: Clinical and experimental observations in five cases occurring in adults. Arch Dermatol 1930;22:655-80.
9. Bennett ML, Jackson JM, Jorizzo JL, Fleischer AB Jr, White WL, Callen JP. Pyoderma gangrenosum. A comparison of typical and atypical forms with an emphasis on time to remission. Case review of 86 patients from 2 institutions. Medicine (Baltimore) 2000;79:37-46.
10. Callen JP. Pyoderma gangrenosum. Lancet 1998;351:581-5.
11. Seitzinger JW. Pyoderma gangrenosum. N J Med 1989;86-465-467
12. Lear JT, Atherton MT, Byrne JP. Neutrophilic dermatoses: Pyoderma gangrenosum and Sweet's syndrome. Postgrad Med J 1977;73:65-8.
13. Powell FC, Su WP, Perry HO. Pyoderma gangrenosum: Classification and management. J Am Acad Dermatol 1996;34:395-409.
14. Hurwitz RM, Haseman JH. The evolution of pyoderma gangrenosum. A clinicopathologic correlation. Am J Dermatopathol 1993;15:28-33.
15. Su WPD, Schroeter AL, Perry HO. Histopathologic and immunopathological study of pyoderm gangrenosum. J Cutan Pathol 1986;13:323-30.
16. Chow RKP, Ho VC. Treatment of pyoderma gangrenosum. J Am Acad Dermatol 1996;34:1047-60.
17. Tremaine WJ. Treatment of erythema nodosum, aphthous stomatitis, and pyoderma gangrenosum in patients with IBD. Inflamm Bowel Dis 1998;4:68-9.
18. Lamers CB. Treatment of extraintestinal complications of ulcerative colitis. Eur J Gastroenterol Hepatol 1997;9:850-3.
19. Futami H, Kodaira M, Furuta T, Hanai H, Kaneko E. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and cyclosporine. J Gastroenterol 1998;33:408-11.
20. Carp JM, Onuma E, Das K, Gottlieb AB. Intravenous cyclosporine therapy in the treatment of pyoderma gangrenosum secondary to Crohn's disease. Cutis 1997;60:135-8.
21. Galun E, Flugelman MY, Rachmilewitz D. Pyoderma gangrenosum complicating ulcerative colitis: Successful treatment with methylprednisolone pulse therapy and dapsone. Am J Gastroenterol 1986;81:988-9.
22. Regueiro M, Valentine J, Plevy S, Fleicher MR, Lichtenstein GR. Infliximab for treatment of pyoderma gangrenosum associated with inflammatory bowel disease. Am J Gastroenterol 2003;98(8):1821-6.